Quote
—
—
We have scored 50 news catalysts on MOH (MOH) over the past 12 months. Coverage across the window leans negative (average ticker sentiment −0.33). Most of the impact sits in forward growth expectations and earnings revision trend.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
No scored news tagged MOH or its network in the window yet.
Show more MOH articles →Analysts publish price targets on MOH, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
16 analyst price targets from $163 to $286
as of 2026-09-06
The market is within 7% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about MOH — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of MOH, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for MOH: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The price sits at the 31st percentile of published models, roughly 7% below the median, meaning it pays for the base-case recovery but explicitly rejects the most optimistic growth and the most pessimistic loss scenarios.
What the disagreement turns on
Does the Marketplace segment's 79% revenue growth translate into durable margin expansion, or does it drag the medical loss ratio higher and compress earnings; unit volume data can track the membership, but it cannot settle the margin question.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
